Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c
Get Alerts PCYC Hot Sheet
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of $1.14, $0.39 better than the analyst estimate of $0.75. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $87.64 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Agnico Eagle Mines (AEM) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!